Clinical Trial Update: A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT) [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial assessing the efficacy of omalizumab in atopic asthmatics with good lung capacity who remain difficult to treat, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2011-12-08